Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5857)
All Articles published online
|
Publishing Process of This Article
|
Nov 12, 2019 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gianassi I, Allinovi M, Caroti L, Cirami LC. Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature. World J Nephrol 2019; 8(7): 109-117 [PMID: 31750091 DOI: 10.5527/wjn.v8.i7.109] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v8/i7/109.htm |
| Number | Citing Articles |
| 1 |
Hua Miao, Yamei Zhang, Xiaoyong Yu, Liang Zou, Yingyong Zhao. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.969930
|
| 2 |
Yan-Ni Wang, Hao-Yu Feng, Xin Nie, Ya-Mei Zhang, Liang Zou, Xia Li, Xiao-Yong Yu, Ying-Yong Zhao. Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.907108
|
| 3 |
Satori Akita, Kosuke Fujibayashi, Ei-ichi Ueno, Minoru Wakasa, Yasuyuki Kawai, Kouji Kajinami. Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis: A Case Report and Review of Literature. Internal Medicine 2024; 63(8): 1113 doi: 10.2169/internalmedicine.1846-23
|
| 4 |
Shubhangi Gumbar, Sudeep Bhardwaj, Sidharth Mehan, Zuber Khan, Acharan S. Narula, Reni Kalfin, Shams Tabrez, Torki A. Zughaibi, Samina Wasi. Renal mitochondrial restoration by gymnemic acid in gentamicin-mediated experimental nephrotoxicity: evidence from serum, kidney and histopathological alterations. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1218506
|
| 5 |
Zhaocheng Dong, Haoran Dai, Wenbin Liu, Hanxue Jiang, Zhendong Feng, Fei Liu, Qihan Zhao, Hongliang Rui, Wei Jing Liu, Baoli Liu. Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.770902
|
| 6 |
Gina Córdoba-David, Jorge García-Giménez, Regiane Cardoso Castelo-Branco, Susana Carrasco, Pablo Cannata, Alberto Ortiz, Adrián M. Ramos. Crosstalk between TBK1/IKKε and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.987979
|
| 7 |
Ying-Yong Zhao. Recent advances of gut microbiota in chronic kidney disease patients. Exploration of Medicine 2022; : 260 doi: 10.37349/emed.2022.00090
|
| 8 |
T.A. Garkusha, E.S. Stolyarevich, V.A. Khorzhevskii, S.V. Ivliev, M.A. Firsov. Pathology of the kidneys in malignant tumors of various localizations and antitumor therapy. Russian Journal of Archive of Patology 2024; 86(3): 59 doi: 10.17116/patol20248603159
|
| 9 |
Benjamin Lai, Shue-Fen Luo, Jenn-Haung Lai. Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1489205
|